Please use this identifier to cite or link to this item:
https://ir.swu.ac.th/jspui/handle/123456789/12503
Title: | Effects of Brassica oleracea extract on impaired glucose and lipid homeostasis in high-fat diet-induced obese mice |
Authors: | Nanna U. Naowaboot J. Chularojmontri L. Tingpej P. Wattanapitayakul S. |
Keywords: | acetyl coenzyme A carboxylase antidiabetic agent Brassica oleracea extract cholesterol fatty acid fatty acid synthase glucose insulin leptin plant extract sterol regulatory element binding protein 1c triacylglycerol unclassified drug animal experiment animal model animal tissue Article Brassica oleracea cholesterol blood level controlled study diet induced obesity fatty acid blood level gene expression glucose homeostasis hormone blood level impaired glucose tolerance insulin blood level insulin sensitivity lipid blood level lipid diet lipid homeostasis lipogenesis male mouse nonhuman priority journal treatment duration triacylglycerol blood level |
Issue Date: | 2019 |
Abstract: | Objective: To examine the effect of Brassica oleracea extract (BO) on impaired glucose and lipid homeostasis in high-fat diet (HFD)-induced obese mice. Methods: Obesity of ICR mice was induced by feeding a HFD (45 kcal% lard fat) for 16 weeks. During the last 8 weeks of study period, obese mice were additionally administered with BO (100 and 200 mg/kg/day). The metabolic parameters were determined. The gene expressions of hepatic lipogenesis were also studied. Results: After 8 weeks of treatment, BO (100 and 200 mg/kg) significantly reduced hyperglycemia and improved insulin sensitivity (P < 0.05). The serum lipid (total cholesterol, triglyceride, and non-esterified fatty acid) and hepatic triglyceride and non-esterified fatty acid were decreased (P < 0.05). The levels of insulin and leptin in serum were also decreased (P < 0.05). Moreover, the expressions of hepatic lipogenic genes including sterol regulatory element-binding protein 1c, fatty acid synthase, and acetyl-CoA carboxylase were decreased by BO treatment (P < 0.05). Conclusions: These results suggest that BO is a new therapeutic agent for improving the homeostasis of glucose and lipid in HFD-induced obese mice probably by suppression of lipogenic genes in liver tissue. © 2019 Asian Pacific Journal of Tropical Biomedicine Produced by Wolters Kluwer-Medknow. |
URI: | https://ir.swu.ac.th/jspui/handle/123456789/12503 https://www.scopus.com/inward/record.uri?eid=2-s2.0-85061075624&doi=10.4103%2f2221-1691.250859&partnerID=40&md5=e94451058ffd29e9686f6d8b93de9b6f |
ISSN: | 22211691 |
Appears in Collections: | Scopus 1983-2021 |
Files in This Item:
There are no files associated with this item.
Items in SWU repository are protected by copyright, with all rights reserved, unless otherwise indicated.